THE LATEST

GRABAR LAW OFFICE INVESTIGATES POTENTIAL SHAREHOLDER DERIVATIVE ACTION ON BEHALF OF SHAREHOLDERS OF CABOT OIL & GAS CORPORATION (NYSE: COG)

By Grabar Law | Sep 18, 2020

The investigation focuses on whether the Company’s Board of Directors and/or officers breached their fiduciary duties. It is alleged that ...

Interior Molded Door Manufacturers Agree to Settle class actions for $75 million.

By Grabar Law | Sep 18, 2020

Defendant door makers Jeld-Wen and Masonite were accused of using their market dominance to fix the prices for indoor molded ...

Grabar Law Office Files Class Action Complaint Against Manufacturers of the Pharmaceutical Drug Bystolic®

By Grabar Law | Sep 8, 2020

The Class Action Complaint against AbbVie, Inc. (“AbbVie”); Allergan, Inc., Allergan Sales, LLC, and Allergan USA, Inc. (collectively, “Allergan”); and ...

Grabar Law Office Files Shareholder Derivative Action Against Officers and Directors Of FirstEnergy Corporation

By Grabar Law | Sep 4, 2020

As alleged in the Complaint, Defendants adopted a corporate policy of providing illegal payments to government officials, including Ohio Speaker ...

Grabar Law Office Files Shareholder Derivative Action Against Officers and Directors Of Under Armour, Inc.

By Grabar Law | Sep 1, 2020

This action arises out of the Defendants’ knowing, conscious, and intentional failure to: (1) adhere to accepted accounting principles regarding ...

Grabar Law Office Files Complaint To Compel Inspection Of Books And Records Of Fifth Third Bancorp (NASDAQ: FITB)

By Grabar Law | Aug 31, 2020

Plaintiff seeks to inspect books and records of Fifth Third to: (i) investigate potential wrongdoing, mismanagement, and breaches of fiduciary ...

Grabar Law Office Investigates Potential Shareholder Derivative Action on Behalf of Shareholders of Cabot Oil & Gas Corporation (NYSE: COG)

By Grabar Law | Aug 23, 2020

The investigation focuses on whether the Company’s Board of Directors and/or officers breached their fiduciary duties. It is alleged that ...

Grabar Law Office Files Antitrust Class Action Against Archer Daniels Midland Company For Manipulating the Price of Ethanol

By Grabar Law | Jul 27, 2020

As alleged in the complaint, by depressing prices at Argo, ADM depressed the revenues which Plaintiff and other ethanol producers ...

Grabar Law Office Files Putative Class Action Alleging Manipulation of U.S. Treasury Futures and Eurodollar Futures

By Grabar Law | Jul 24, 2020

This action arises from Deutsche Bank’s unlawful and intentional manipulation of U.S. Treasury Futures contracts and options on Treasury Futures ...

Grabar Law Office Files Shareholder Derivative Action Against Officers of Healthcare Services Group, Inc.

By Grabar Law | Jul 14, 2020

Grabar Law Office has filed a derivative action brought on behalf of the public stockholders of Healthcare Services Group, Inc. ...

« Previous
1
…
7
8
9
10
11
…
16
Next »

Grabar Law Office In the News: Alto Neuroscience Execs Sued Over Rosy Drug Claims

By Grabar Law | Oct 9, 2025

An Alto Neuroscience investor claims CEO Amit Etkin and other directors overstated the efficacy of the psychiatric biotech company's lead ...

Grabar Law Office In the News: Marijuana Vape Antitrust Actions Consolidated In Calif.

By Grabar Law | Oct 9, 2025

Five proposed antitrust class actions brought by buyers of CCell brand cannabis vape accusing the Chinese manufacturers and U.S. distributors ...

Grabar Law Office In the News: DOJ Asks for Stay in PVC Antitrust Case Amid Criminal Probe

By Grabar Law | Oct 9, 2025

The U.S. Department of Justice is asking an Illinois federal court to pause discovery in a case accusing polyvinyl chloride ...

Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims

By Grabar Law | Aug 26, 2025

Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...

Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims

By Grabar Law | Aug 26, 2025

Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...

Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania

By Grabar Law | Jul 11, 2025

Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United ...

Grabar Law Office In the News: Geron Shareholder Sues Execs Over Drug Launch Claims

By Grabar Law | Apr 19, 2025

A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top ...

Grabar Law Office In the News: AI Audio Co. Brass Accused of Acquisition Accounting Errors

By Grabar Law | Apr 19, 2025

Executives and directors of California-based voice recognition technology company SoundHound Inc. were hit with a shareholder derivative suit alleging they ...